Konrad J Werhahn1. 1. Neurologische Klinik, Mainzer Epilepsie Zentrum, Johannes Gutenberg-Universität Mainz. werhahn@uni-mainz.de
Abstract
BACKGROUND: Epilepsy is the third most common disease affecting the brain in the elderly. Current demographic trends will lead to an increased prevalence of epilepsy in the general population. METHOD: A selective literature search revealed 102 relevant publications as of September 2008, 50 of which were original articles. RESULTS: The level of evidence was found to be very low. No guidelines, systematic reviews or meta-analyses are available, and there have been only three randomized, double-blind trials of treatment for epilepsy in the elderly. The seizures often escape clinical attention, because premonitory symptoms (aura) and secondary generalization into tonic-clonic seizures are both rarer in older patients. On the other hand, sudden loss of consciousness from various causes becomes more common with increasing age, presenting a challenge in differential diagnosis. Treatment is often more complex because of comorbidities and multiple other drugs, and requires a cautious approach. Drug interactions, in particular, require special attention. On the positive side, epileptic seizures in the elderly seem to be more easily controlled by medications than they are in young adults. CONCLUSIONS: Epilepsy is often more difficult to recognize in old age. The treatment is hampered by side effects and drug interactions. Thus, certainty about the diagnosis is indispensable, and the treatment often requires the use of newer-generation antiepileptic drugs.
BACKGROUND:Epilepsy is the third most common disease affecting the brain in the elderly. Current demographic trends will lead to an increased prevalence of epilepsy in the general population. METHOD: A selective literature search revealed 102 relevant publications as of September 2008, 50 of which were original articles. RESULTS: The level of evidence was found to be very low. No guidelines, systematic reviews or meta-analyses are available, and there have been only three randomized, double-blind trials of treatment for epilepsy in the elderly. The seizures often escape clinical attention, because premonitory symptoms (aura) and secondary generalization into tonic-clonic seizures are both rarer in older patients. On the other hand, sudden loss of consciousness from various causes becomes more common with increasing age, presenting a challenge in differential diagnosis. Treatment is often more complex because of comorbidities and multiple other drugs, and requires a cautious approach. Drug interactions, in particular, require special attention. On the positive side, epilepticseizures in the elderly seem to be more easily controlled by medications than they are in young adults. CONCLUSIONS:Epilepsy is often more difficult to recognize in old age. The treatment is hampered by side effects and drug interactions. Thus, certainty about the diagnosis is indispensable, and the treatment often requires the use of newer-generation antiepileptic drugs.
Authors: H Stefan; L Hubbertz; I Peglau; J Berrouschot; B Kasper; A Schreiner; J Krimmer; B Schauble Journal: Acta Neurol Scand Date: 2008-03-31 Impact factor: 3.209
Authors: R H Mattson; J A Cramer; J F Collins; D B Smith; A V Delgado-Escueta; T R Browne; P D Williamson; D M Treiman; J O McNamara; C B McCutchen Journal: N Engl J Med Date: 1985-07-18 Impact factor: 91.245
Authors: Brit Mollenhauer; Hans Förstl; Günther Deuschl; Alexander Storch; Wolfgang Oertel; Claudia Trenkwalder Journal: Dtsch Arztebl Int Date: 2010-10-01 Impact factor: 5.594
Authors: Derek H Tang; Daniel C Malone; Terri L Warholak; Jenny Chong; Edward P Armstrong; Marion K Slack; Chiu Hsieh Hsu; David M Labiner Journal: J Clin Neurol Date: 2015-05-28 Impact factor: 3.077
Authors: Carlos Clayton Torres Aguiar; Anália Barbosa Almeida; Paulo Victor Pontes Araújo; Rita Neuma Dantas Cavalcante de Abreu; Edna Maria Camelo Chaves; Otoni Cardoso do Vale; Danielle Silveira Macêdo; David John Woods; Marta Maria de França Fonteles; Silvania Maria Mendes Vasconcelos Journal: Oxid Med Cell Longev Date: 2012-07-14 Impact factor: 6.543
Authors: Lena Rubi; Ulla Schandl; Michael Lagler; Petra Geier; Daniel Spies; Kuheli Das Gupta; Stefan Boehm; Helmut Kubista Journal: Neuromolecular Med Date: 2013-05-22 Impact factor: 3.843